A detailed history of Old Mission Capital LLC transactions in Argenx Se stock. As of the latest transaction made, Old Mission Capital LLC holds 10,771 shares of ARGX stock, worth $5.84 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,771
Previous 777 1286.23%
Holding current value
$5.84 Million
Previous $305,000 1418.36%
% of portfolio
0.13%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $3.56 Million - $4.51 Million
9,994 Added 1286.23%
10,771 $4.63 Million
Q1 2024

May 14, 2024

BUY
$356.95 - $413.29 $277,350 - $321,126
777 New
777 $305,000
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $4.76 Million - $5.59 Million
-13,903 Reduced 86.63%
2,145 $812,000
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $5.51 Million - $6.35 Million
16,048 New
16,048 $5.67 Million
Q3 2021

Nov 12, 2021

SELL
$295.0 - $350.58 $2.16 Million - $2.57 Million
-7,317 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$257.11 - $319.92 $1.51 Million - $1.88 Million
5,882 Added 409.9%
7,317 $2.2 Million
Q1 2021

May 14, 2021

BUY
$268.3 - $380.31 $385,010 - $545,744
1,435 New
1,435 $395,000
Q3 2020

Nov 16, 2020

SELL
$215.51 - $272.51 $6.02 Million - $7.62 Million
-27,949 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$127.44 - $232.72 $3.56 Million - $6.5 Million
27,949 New
27,949 $6.3 Million
Q1 2020

May 15, 2020

SELL
$108.83 - $165.23 $2.73 Million - $4.15 Million
-25,114 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$106.59 - $164.21 $87,830 - $135,309
-824 Reduced 3.18%
25,114 $4.03 Million
Q3 2019

Nov 14, 2019

BUY
$113.31 - $150.51 $2.94 Million - $3.9 Million
25,938 New
25,938 $2.96 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $451,260 - $555,559
-3,924 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$98.85 - $134.59 $387,887 - $528,131
3,924 New
3,924 $490,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $30B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.